Nathan Moore, MD
Family Medicine · Paris, KYNPI 1093829822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $597 and has fallen 97.5% since, to $15 in 2022.
Across 100 payments — averaging $13.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$184
- GSK$180
- Novartis$178
- Pfizer$171
- Novo Nordisk$120
- Lilly USA, LLC$112
- plus $451 from 10 others
What the payments were for
- Food & beverage$1,396100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $184 |
| GSK | 11 | $180 |
| Novartis | 10 | $178 |
| Pfizer | 20 | $171 |
| Novo Nordisk | 8 | $120 |
| Lilly USA, LLC | 7 | $112 |
| Sanofi-aventis U.S. LLC | 7 | $101 |
| Amarin Pharma, Inc. | 5 | $74 |
| Astellas Pharma US Inc | 3 | $61 |
| Merck | 4 | $51 |
| AstraZeneca | 3 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$1,396 in reported general payments places this provider in the 60th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 11 | $219 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Paris
- Christopher RhyneLouisville$933K
- John RichardLexington$226K
- James TurnboPaducah$124K
- Edward SchumannFlorence$79K
- Ronald KoffNew Castle$71K
- Suraj GathaniLouisville$69K
- Bradley GrayFlorence$51K
- Jackie KazeeAshland$45K
- Mandy WhittLouisville$38K
- Derek JonesAshland$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.